MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Open Forum Infectious Diseases
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,365 results · 1 filter active ·
Results by year
20112025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,365 works in the cohort · of 4,299,418page 24 of 28

Labels cover 2 of 1,365 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,365 of 1,365 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affaboutunlabeled
1165. Longitudinal Evaluation of SARS-CoV-2 Antibody Response Using Dried Blood Spot Samples Following Vaccination with Three and Four Doses of mRNA-1273, BNT162b2 and/or ChAdOx1-S in Adults Aged 50 and Above: Interim Analysis from the PREVENT-COVID Study
Brynn McMillan, Gabrielle N. Gaultier, Ana Márquez, Tahereh Valadbeigy, Bonny So, Sydney Schwartz +13 more
2023· article· en· Open Forum Infectious Diseases· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affaboutunlabeled
729. I Can CPO Clearing Now, the Iso is Gone
Danielle R. Schwartz, Kailee Trepanier, Ellina Lytvyak, Michael Zakhary, Joseph Kim, Uma Chandran
2023· article· en· Open Forum Infectious Diseases· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · insufficient_payloadconsensus · none
0
citations
affaboutunlabeled
2383. <i>In Vitro</i> Activity of Ceftolozane–Tazobactam in Comparison With Ceftazidime–Avibactam vs. Antimicrobial Non-Susceptible <i>Pseudomonas aeruginosa</i> Clinical Isolates, Including Multidrug-Resistant and Extensively Drug-Resistant Subsets: CANWARD, 2007–2017
Andrew Walkty, Heather J. Adam, Melanie Baxter, Philippe Lagacé‐Wiens, James A. Karlowsky, Daryl J. Hoban +1 more
2018· article· en· Open Forum Infectious Diseases· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About